May 2005
Volume 46, Issue 13
Free
ARVO Annual Meeting Abstract  |   May 2005
XIAP (X–Linked Inhibitor of Apoptosis) Gene Therapy Protects Photoreceptors in Animal Models of Retinitis Pigmentosa (RP)
K.C. Leonard; D. Petrin; S.G. Coupland; A.N. Baker; B.C. Leonard; R.G. Korneluk; C. Tsilfidis
Author Affiliations & Notes
  • K.C. Leonard
    Cellular & Molecular Medicine,
    Univ Ottawa Eye Institute, Ottawa, ON, Canada
  • D. Petrin
    Biochemistry & Molecular Immunology,
    Univ Ottawa Eye Institute, Ottawa, ON, Canada
  • S.G. Coupland
    Ophthalmology,
    Univ Ottawa Eye Institute, Ottawa, ON, Canada
  • A.N. Baker
    Ottawa Health Research Institute,
    Univ Ottawa Eye Institute, Ottawa, ON, Canada
  • B.C. Leonard
    Ophthalmology,
    Univ Ottawa Eye Institute, Ottawa, ON, Canada
  • R.G. Korneluk
    Biochemistry & Molecular Immunology, Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON, Canada
  • C. Tsilfidis
    Cellular & Molecular Medicine,
    Univ Ottawa Eye Institute, Ottawa, ON, Canada
  • Footnotes
    Commercial Relationships  K.C. Leonard, None; D. Petrin, None; S.G. Coupland, None; A.N. Baker, None; B.C. Leonard, None; R.G. Korneluk, Aegera Therapeutics C, P; C. Tsilfidis, None.
  • Footnotes
    Support  Canadian Institutes of Health Research, FFB–Canada , FFB–US , Canadian Genetic Diseases Network
Investigative Ophthalmology & Visual Science May 2005, Vol.46, 4693. doi:
  • Views
  • Share
  • Tools
    • Alerts
      User Alerts
      You are adding an alert for:
      XIAP (X–Linked Inhibitor of Apoptosis) Gene Therapy Protects Photoreceptors in Animal Models of Retinitis Pigmentosa (RP)
      You will receive an email whenever this article is corrected, updated, or cited in the literature. You can manage this and all other alerts in My Account
      The alert will be sent to:
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation
      Citation

      K.C. Leonard, D. Petrin, S.G. Coupland, A.N. Baker, B.C. Leonard, R.G. Korneluk, C. Tsilfidis; XIAP (X–Linked Inhibitor of Apoptosis) Gene Therapy Protects Photoreceptors in Animal Models of Retinitis Pigmentosa (RP) . Invest. Ophthalmol. Vis. Sci. 2005;46(13):4693.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

      ×
    • Get Permissions
  • Supplements
Abstract

Abstract: : Purpose: XIAP inhibits apoptosis by blocking the action of caspases 3, 7 and 9. The current study assessed XIAP rescue of photoreceptors in transgenic rat models of RP. Methods: The P23H and S334ter transgenic models of RP were used to test the neuroprotective effects of XIAP gene therapy. Recombinant adeno–associated virus (AAV) encoding either XIAP or green fluorescent protein (GFP; injection control) was injected subretinally into one eye of heterozygous transgenic rat pups at approximately postnatal day 16. The contralateral eye served as an uninjected control. Electroretinograms (ERGs) were recorded at biweekly intervals for up to 32 weeks post–injection. Eyes were examined at various timepoints using histology and immunohistochemistry. Results: Western analysis confirmed the over–expression of XIAP in virus–injected eyes. Significant structural protection of the photoreceptors was evident in the XIAP–injected eye by 16 weeks post–injection in both the P23H and S334ter lines. No preservation of photoreceptor morphology was found in the contralateral uninjected eye, or the GFP–injected control eyes. Immunohistochemistry confirmed the co–localization of XIAP transgene expression with the area showing structural protection. ERG analysis showed preservation of photoreceptor function in the XIAP–treated eye in comparison to both uninjected and GFP–injected control eyes. Conclusions: AAV–mediated delivery of XIAP to the photoreceptor cells seems to provide both structural and functional protection in two models of retinal degeneration. This gene therapy strategy holds great promise for the treatment of RP, as it allows for the broad protection of photoreceptors, regardless of the initial disease causing mutation. The long time course and progressive nature of RP implies that even if intervention is implemented after diagnosis, there is still hope the XIAP will significantly delay, if not completely halt the disease progression.

Keywords: apoptosis/cell death • gene transfer/gene therapy • retinal degenerations: cell biology 
© 2005, The Association for Research in Vision and Ophthalmology, Inc., all rights reserved. Permission to republish any abstract or part of an abstract in any form must be obtained in writing from the ARVO Office prior to publication.
Copyright © 2024 Association for Research in Vision and Ophthalmology.
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×
This site uses cookies. By continuing to use our website, you are agreeing to our privacy policy.Accept